Cidara Therapeutics

Cidara Therapeutics is a biotechnology company focused on the discovery, development and commercialization of anti-infectives for the treatment of diseases. The company's primary product candidate is rezafungin acetate, an intravenous formulation of an echinocandin, which is being developed as a therapy for the treatment and prevention of fungal infections. In addition, the company is developing its antibody-drug conjugates for multidrug-resistant bacterial infections as part of its proprietary Cloudbreak? platform, which is designed to discover compounds that directly kill pathogens and also direct a patient's immune system to attack and eliminate bacterial, fungal or viral pathogens.
  • TickerCDTX
  • ISINUS1717571079
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for CDTX

ValuEngine Rating and Forecast Report for CDTX

Ashiq Mubarack ...
  • David Nierengarten
  • Robert Driscoll

Downgrading to NEUTRAL and reducing PT to $2; Financing Risk Significant

Ashiq Mubarack ...
  • David Nierengarten
  • Robert Driscoll

Downgrading to NEUTRAL and reducing PT to $2; Financing Risk Significant

ValuEngine Rating and Forecast Report for CDTX

ValuEngine Rating and Forecast Report for CDTX

ValuEngine Rating and Forecast Report for CDTX

ValuEngine Rating and Forecast Report for CDTX

ValuEngine Rating and Forecast Report for CDTX

ValuEngine Rating and Forecast Report for CDTX

ValuEngine Rating and Forecast Report for CDTX

ValuEngine Rating and Forecast Report for CDTX

ValuEngine Rating and Forecast Report for CDTX

ValuEngine Rating and Forecast Report for CDTX

ResearchPool Subscriptions

Get the most out of your insights

Get in touch